🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
We want to learn if dasatinib will make triple negative breast cancers smal...
Status
Terminated
Location
Baylor College of Medicine, Lester and Sue Smith Breast Center
Start Date
2008-12
Trial ID
NCT00817531
Treatments Being Tested
This study will enroll CML patients who have failed a first TKI stopping at...
Status
Unknown
Location
Aarhus University Hospital
Start Date
2018-02-01
Trial ID
NCT03573596
Treatments Being Tested
The goal of this clinical research study is to learn if combining Sprycel (...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-06-12
Trial ID
NCT01498445
Treatments Being Tested
The purpose of this pilot study is to demonstrate the safety and feasibilit...
Status
Completed
Location
Hebrew Senior Life
Start Date
2022-05-20
Trial ID
NCT05422885
This is an open-label, safety study of cetuximab and differing dose levels ...
Status
Completed
Location
University of Pittsburgh Cancer Institute - Hillman Cancer Center
Start Date
2007-06
Trial ID
NCT00388427
Treatments Being Tested
The objective is to evaluate the cytogenetic response to Dasatinib (BMS-354...
Status
Completed
Location
Local Institution
Start Date
2007-05
Trial ID
NCT00482703
To determine if senolytic drugs reduce senescent cell burden and reduce bon...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2020-06-09
Trial ID
NCT04313634
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2007-06
Trial ID
NCT00495872
Treatments Being Tested
The purpose of the study is to determine the safety and tolerability of the...
Status
Completed
Location
University Of California Medical Center
Start Date
2011-01
Trial ID
NCT01218477
Treatments Being Tested
Clinically demonstrated efficacy of Melphalan and Prednisone in MM subjects...
Status
Terminated
Location
Mario Boccadoro
Start Date
2008-02
Trial ID
NCT01116128
Treatments Being Tested